June 14, 2022
Article
Amy Paller, MD, sits down to answer important questions on the FDA approval of dupilumab for patients aged 6 months to 5 years.
June 08, 2022
Article
Sanofi and Regeneron Pharmaceuticals, Inc announced the FDA approval of dupilumab. It is now the first biologic medicine for children from 6 months to 5 years old with moderate to severe atopic dermatitis.
June 08, 2022
Article
Kenneth J. Tomecki, MD, discussed the clinical relevance of sexually transmitted diseases to dermatology and outlined what to look for and how to treat various conditions at the 2022 Fall Clinical Dermatology Conference for PAs & NPs.
May 16, 2022
Article
Teenagers were the most likely to be affected by targeted misinformation.
May 05, 2022
Article
Allergic contact dermatitis and atopic dermatitis are common causes of rashes in the pediatric population. Patch testing can help demystify the cause of such skin conditions and determine treatment.
April 28, 2022
Article
The American Academy of Dermatology’s survey finds more Americans say sun protection is more important than 5 years ago, but don’t understand how to protect themselves.